STAGE IV PANCREATIC CANCER
Clinical trials for STAGE IV PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for STAGE IV PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase study tested a new drug called sEphB4-HSA combined with standard chemotherapy in 61 people with advanced or metastatic solid tumors (like head and neck, pancreatic, lung, and gallbladder cancers). The goal was to find the best dose and check for side effects. Whi…
Matched conditions: STAGE IV PANCREATIC CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug cocktail shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called ceralasertib, either alone or combined with olaparib or durvalumab, in people with advanced solid tumors like kidney, bladder, pancreatic, endometrial, and prostate cancers. The goal is to see if these combinations can shrink tumors or slow their gr…
Matched conditions: STAGE IV PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Rahul Aggarwal • Aim: Disease control
Last updated May 18, 2026 11:59 UTC